These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7664609)

  • 1. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation].
    Jin Z; Zhang X; Feng Y
    Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.
    Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS
    Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of liposome-C-erbB2 antisense oligodeoxynucleotides on human ovarian cancer cells].
    Shen M; Feng Y; Ge B
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):485-7. PubMed ID: 11360601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer].
    Yin D; Zhang X; Feng Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):291-2. PubMed ID: 9206183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antisense c-erbB2 on biologic behaviour and chemotherapeutic drug sensitivity in human ovarian cancer cells].
    Wu L; Wu A; Jiang K
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):169-72. PubMed ID: 8758793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
    Watson JM; Berek JS; Martínez-Maza O
    Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells.
    Shen M; Feng Y; Ge B; Wu Z; Zhu M
    Chin Med J (Engl); 2001 Jul; 114(7):735-7. PubMed ID: 11780339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors].
    Hou Y; Wang M; Liu W
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):426-8. PubMed ID: 9387293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance].
    Yang H; Zhang G; Xu K
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):367-70. PubMed ID: 10921034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.
    Muthukumaran N; Miletti-González KE; Ravindranath AK; Rodríguez-Rodríguez L
    Mol Cancer Res; 2006 Aug; 4(8):511-20. PubMed ID: 16908592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.
    Yang WL; Roland IH; Godwin AK; Xu XX
    Oncogene; 2005 Dec; 24(54):7991-8002. PubMed ID: 16044148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
    Marth C; Müller-Holzner E; Greiter E; Cronauer MV; Zeimet AG; Doppler W; Eibl B; Hynes NE; Daxenbichler G
    Cancer Res; 1990 Nov; 50(21):7037-41. PubMed ID: 2119884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
    Fei R; Shaoyang L
    Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on transfer of interleukin-7 gene into ovarian carcinoma cells in vitro].
    Cheng B; Chen HZ; Ye DF; Lu WG; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):199-202. PubMed ID: 12885363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
    Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.